SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21829041
Source:
http://linkedlifedata.com/resource/pubmed/id/21829041
Search
Subject
(
65
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007134
,
umls-concept:C0030705
,
umls-concept:C0078988
,
umls-concept:C0205179
,
umls-concept:C0600688
,
umls-concept:C1176020
,
umls-concept:C1979963
,
umls-concept:C2003903
pubmed:issue
5-6
pubmed:dateCreated
2011-9-6
pubmed:abstractText
We aimed to describe the efficacy and safety of sunitinib in unselected Korean advanced renal cell carcinoma (RCC) patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0135054
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles
,
http://linkedlifedata.com/resource/pubmed/chemical/sunitinib
pubmed:status
MEDLINE
pubmed:issn
1423-0232
pubmed:author
pubmed-author:AhnJoong-BaeJB
,
pubmed-author:BangYung-JueYJ
,
pubmed-author:ChungHyun CheolHC
,
pubmed-author:HongMin HeeMH
,
pubmed-author:JeungHei ChulHC
,
pubmed-author:KimHyo SongHS
,
pubmed-author:KimKiyeolK
,
pubmed-author:KohYoungilY
,
pubmed-author:LeeSe-HoonSH
,
pubmed-author:RhaSun YoungSY
,
pubmed-author:ShinSang-JoonSJ
pubmed:copyrightInfo
Copyright © 2011 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
395-405
pubmed:meshHeading
pubmed-meshheading:21829041-Adult
,
pubmed-meshheading:21829041-Aged
,
pubmed-meshheading:21829041-Anemia
,
pubmed-meshheading:21829041-Antineoplastic Agents
,
pubmed-meshheading:21829041-Asian Continental Ancestry Group
,
pubmed-meshheading:21829041-Carcinoma, Renal Cell
,
pubmed-meshheading:21829041-Disease-Free Survival
,
pubmed-meshheading:21829041-Drug Administration Schedule
,
pubmed-meshheading:21829041-Female
,
pubmed-meshheading:21829041-Humans
,
pubmed-meshheading:21829041-Indoles
,
pubmed-meshheading:21829041-Kidney Neoplasms
,
pubmed-meshheading:21829041-Male
,
pubmed-meshheading:21829041-Middle Aged
,
pubmed-meshheading:21829041-Neutropenia
,
pubmed-meshheading:21829041-Nomograms
,
pubmed-meshheading:21829041-Predictive Value of Tests
,
pubmed-meshheading:21829041-Pyrroles
,
pubmed-meshheading:21829041-Republic of Korea
,
pubmed-meshheading:21829041-Risk Factors
,
pubmed-meshheading:21829041-Thrombocytopenia
,
pubmed-meshheading:21829041-Treatment Outcome
pubmed:year
2011
pubmed:articleTitle
Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.
pubmed:affiliation
Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchondong, Seodaemun-gu, Seoul, Korea.
pubmed:publicationType
Journal Article
,
Clinical Trial